Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

SNDXSNDX
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in SYNDAX PHARMACEUTICALS INC

BNP PARIBAS FINANCIAL MARKETS holds 32,601 shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $712,658 as of 2026-Q2. The position was decreased (-19.3% shares). SNDX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.

Current Value

$712,658

Current Shares

32,601

Total Value Change

+$306,502

Total Shares Change

+11,502

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
32,601
-19.3%
$712,6580.0%$21.86
0
2026-Q1
Increased
40,381
+183.8%
$943,3000.0%$21.40
40
2025-Q4
Decreased
14,228
-97.6%
$298,9300.0%$20.74
0
2025-Q3
Increased
599,871
+20.0%
$9.2M0.0%$15.56
33
2025-Q2
Increased
499,903
+130.4%
$4.7M0.0%$9.04
43
2025-Q1
Decreased
216,993
-16.3%
$2.7M0.0%$13.18
0
2024-Q4
Increased
259,245
+1128.7%
$3.4M0.0%$12.52
43
2024-Q3
Increased
21,099
+375.6%
$406,1560.0%$18.89
38

Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used